BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 37085010)

  • 21. Senolytic therapeutics: An emerging treatment modality for osteoarthritis.
    Ansari MM; Ghosh M; Lee DS; Son YO
    Ageing Res Rev; 2024 Apr; 96():102275. PubMed ID: 38494091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular senescence and the aging brain.
    Chinta SJ; Woods G; Rane A; Demaria M; Campisi J; Andersen JK
    Exp Gerontol; 2015 Aug; 68():3-7. PubMed ID: 25281806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell senescence in neuropathology: A focus on neurodegeneration and tumours.
    Carreno G; Guiho R; Martinez-Barbera JP
    Neuropathol Appl Neurobiol; 2021 Apr; 47(3):359-378. PubMed ID: 33378554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights into targeting cellular senescence with senolytic therapy: The journey from preclinical trials to clinical practice.
    Chen P; Wang Y; Zhou B
    Mech Ageing Dev; 2024 Apr; 218():111918. PubMed ID: 38401690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Senescence and Neuroprotective Effects of Telomerase in Neurodegenerative Diseases.
    Ding X; Liu X; Wang F; Wang F; Geng X
    Rejuvenation Res; 2020 Apr; 23(2):150-158. PubMed ID: 31170886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Senotherapeutics for mesenchymal stem cell senescence and rejuvenation.
    Wong PF; Dharmani M; Ramasamy TS
    Drug Discov Today; 2023 Jan; 28(1):103424. PubMed ID: 36332835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential Use of Senolytics for Pharmacological Targeting of Precancerous Lesions.
    Saleh T; Carpenter VJ
    Mol Pharmacol; 2021 Dec; 100(6):580-587. PubMed ID: 34544896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Senotherapeutics in Cancer and HIV.
    Sánchez-Díaz L; Espinosa-Sánchez A; Blanco JR; Carnero A
    Cells; 2022 Apr; 11(7):. PubMed ID: 35406785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Cancer SENESCopedia: A delineation of cancer cell senescence.
    Jochems F; Thijssen B; De Conti G; Jansen R; Pogacar Z; Groot K; Wang L; Schepers A; Wang C; Jin H; Beijersbergen RL; Leite de Oliveira R; Wessels LFA; Bernards R
    Cell Rep; 2021 Jul; 36(4):109441. PubMed ID: 34320349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Translating the Biology of Aging into New Therapeutics for Alzheimer's Disease: Senolytics.
    Riessland M; Orr ME
    J Prev Alzheimers Dis; 2023; 10(4):633-646. PubMed ID: 37874084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting cellular senescence in cancer and aging: roles of p53 and its isoforms.
    Beck J; Turnquist C; Horikawa I; Harris C
    Carcinogenesis; 2020 Aug; 41(8):1017-1029. PubMed ID: 32619002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Senotherapeutics: Targeting senescent cells for the main age-related diseases.
    Boccardi V; Mecocci P
    Mech Ageing Dev; 2021 Jul; 197():111526. PubMed ID: 34166689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application potential of senolytics in clinical treatment.
    Li T; Li S; Ma K; Kong J
    Biogerontology; 2024 Jun; 25(3):379-398. PubMed ID: 38109001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Senolytic and senomorphic agent procyanidin C1 alleviates structural and functional decline in the aged retina.
    Liu Y; Liu X; Chen X; Yang Z; Chen J; Zhu W; Li Y; Wen Y; Deng C; Gu C; Lv J; Ju R; Zhuo Y; Su W
    Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2311028121. PubMed ID: 38657052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein phosphatase 2A activators reverse age-related behavioral changes by targeting neural cell senescence.
    Xing J; Chen K; Gao S; Pousse M; Ying Y; Wang B; Chen L; Wang C; Wang L; Hu W; Lu Y; Gilson E; Ye J
    Aging Cell; 2023 Mar; 22(3):e13780. PubMed ID: 36644807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Senescence-induced changes in CD4 T cell differentiation can be alleviated by treatment with senolytics.
    Lorenzo EC; Torrance BL; Keilich SR; Al-Naggar I; Harrison A; Xu M; Bartley JM; Haynes L
    Aging Cell; 2022 Jan; 21(1):e13525. PubMed ID: 34962049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Senolytic agent Quercetin ameliorates intervertebral disc degeneration via the Nrf2/NF-κB axis.
    Shao Z; Wang B; Shi Y; Xie C; Huang C; Chen B; Zhang H; Zeng G; Liang H; Wu Y; Zhou Y; Tian N; Wu A; Gao W; Wang X; Zhang X
    Osteoarthritis Cartilage; 2021 Mar; 29(3):413-422. PubMed ID: 33242601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New Horizons in cellular senescence for clinicians.
    Witham MD; Granic A; Miwa S; Passos JF; Richardson GD; Sayer AA
    Age Ageing; 2023 Jul; 52(7):. PubMed ID: 37466640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular senescence in bone.
    Farr JN; Khosla S
    Bone; 2019 Apr; 121():121-133. PubMed ID: 30659978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting the microbiota-mitochondria crosstalk in neurodegeneration with senotherapeutics.
    Homolak J
    Adv Protein Chem Struct Biol; 2023; 136():339-383. PubMed ID: 37437983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.